4.2 Article

Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3 alpha

Journal

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Volume 45, Issue 5, Pages 2031-2043

Publisher

KARGER
DOI: 10.1159/000487983

Keywords

Long noncoding RNA; Meg3; Beta cells; MafA; Rad21; Smc3; Sin3 alpha

Funding

  1. National Natural Science Foundation of China [81570697]
  2. Open Research Project of State Key Laboratory of Reproductive Medicine [SKLRM-KF-1201]

Ask authors/readers for more resources

Background/Aims: The main pathogenic mechanism of diabetes is a decrease in the number of islet beta cells or a decline in their function. Recent studies have shown that pancreatic long noncoding RNAs (IncRNAs) have a high degree of tissue specificity and may be involved in the maintenance of islet cells function and the development of diabetes. The aim of this study was to investigate the molecular regulatory mechanism of mouse maternal expressed gene 3 (Meg3) in insulin biosynthesis in pancreatic islets. Methods: Chromatin immunoprecipitation- quantitative polymerase chain reaction (qPCR) and RNA immunoprecipitation-qPCR were used to investigate the molecular mechanism of IncRNA Meg3 in insulin biosynthesis by regulating v-Maf musculoaponeurotic fibrosarcoma oncogene family, protein A (MafA), a mature beta cell marker in the MIN6 beta cell line. Further, the expression levels of Meg3, Ezh2, MafA, Rad21, Srnc3, and Sin3a were analyzed in vivo and in vitro by RT-PCR and western blotting. Results: Intranuclear IncRNA Meg3 can bind EZH2, a methyltransferase belonging to the Polycomb repressive complex-2, in pancreatic islet cells. In addition, knockdown of Ezh2 can also inhibit the expression of MafA and Ins2, while expression levels of Rad21, Smc3, and Sin3 alpha are upregulated, by interfering with Ezh2 or Meg3 in pancreatic beta cells. Knockdown of Meg3 resulted in the loss of EZH2 binding and H3K27 trimethylation occupancy of Rad21, Smc3, and Sin3 alpha promoter regions. The inhibition of Rad21, Smc3, or Sin3 alpha, which directly act on the MafA promoter, leads to upregulated expression of MafA in both MIN6 cells and mouse islets. Moreover, the synthesis and secretion of insulin were increased by inhibition of these transcription factors. Conclusions: Pancreatic IncRNA Meg3 can epigenetically regulate the expression of Rad21, Smc3, and Sin3 alpha via EZH2-driven H3K27 methylation. By inhibiting the expression of Rad21, Smc3(or Sin3 alpha, Meg3 promotes the expression of MafA and affects the production of insulin. (C) 2018 The Author(s) Published by S Karger AG, Basel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available